Search results for "remodeling"

showing 10 items of 357 documents

Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects

2012

Abstract Background Despite the reported high prevalence of osteoporosis in the human immunodeficiency virus (HIV)-population, there have been no previous studies examining dairy calcium intake and bone mineral density (BMD) in HIV-subjects. We assessed the prevalence of low BMD in HIV-infected and uninfected subjects and analyzed the effects of calcium intake, lifestyle and HIV-related risk factors on BMD. Methods One hundred and twelve HIV-infected subjects were consecutively enrolled. Seventy- six HIV-uninfected subjects matched for age and sex were enrolled as the control group. The HIV-subjects were interviewed about lifestyle habits and completed a weekly food-frequency questionnaire …

musculoskeletal diseasesAdultMalemedicine.medical_specialtyFRAXSettore MED/09 - Medicina InternaBone densitySettore MED/17 - Malattie InfettiveOsteoporosisHIV Infectionslcsh:Infectious and parasitic diseasesBone remodelingAbsorptiometry PhotonBone DensityRisk FactorsSurveys and QuestionnairesInternal medicineVitamin D and neurologyBone mineral densityHumansMedicinelcsh:RC109-216Life StyleBone mineralMediterranean Regionbusiness.industryOsteopeniaCase-control studyOsteoporosiHIVMiddle AgedDairy intakemedicine.diseaseDietOsteopeniaInfectious DiseasesEndocrinologyCase-Control StudiesOsteoporosisCalciumFemalebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaResearch Article
researchProduct

Osteoprotegerin: a new biomarker for impaired bone metabolism in complex regional pain syndrome?

2014

Abstract Osteoprotegerin (OPG) is important for bone remodeling and may contribute to complex regional pain syndrome (CRPS) pathophysiology. We aimed to assess the value of OPG as a biomarker for CRPS and a possible correlation with radiotracer uptake in 3-phase bone scintigraphy (TPBS). OPG levels were analyzed in 23 CRPS patients (17 women; mean age 50 ± 9.0 years; disease duration: 12 weeks [IQR 8–24]), 10 controls (6 women; mean age 58 ± 9.6 years) and 21 patients after uncomplicated fractures (12 women; mean age: 43 ± 15 years; time after fracture: 15 weeks [IQR: 6–22]). The CRPS and control patients also underwent TPBS. OPG in CRPS patients was significantly increased by comparison wi…

musculoskeletal diseasesAdultMalemedicine.medical_specialtyGastroenterologySensitivity and SpecificityBone remodeling03 medical and health sciences0302 clinical medicineOsteoprotegerinInternal medicinemedicineHumans030304 developmental biology0303 health sciencesmedicine.diagnostic_testReceiver operating characteristicbusiness.industryArea under the curveOsteoprotegerinMiddle Agedmedicine.diseasePathophysiologyBone Diseases MetabolicAnesthesiology and Pain MedicineEndocrinologyComplex regional pain syndromeNeurologyBone scintigraphyBiomarker (medicine)FemaleNeurology (clinical)business030217 neurology & neurosurgeryBiomarkersComplex Regional Pain SyndromesPainReferences
researchProduct

Monitoring bone growth using quantitative ultrasound in comparison with DXA and pQCT.

2008

Quantitative ultrasound (QUS) is a safe, inexpensive, and nonradiation method for bone density assessment. QUS correlates with, and predicts fragility fractures comparable to, dual-energy X-ray absorptiometry (DXA)-derived bone mineral density (BMD) in postmenopausal women. However, its validity in monitoring bone growth in children is not well understood. Two hundred and fifty-eight 10-13 yr pubertal girls and 9 37-43 yr adults without diseases or history of medications known to affect bone metabolism were included in the 2-yr prospective study. Calcaneal broadband ultrasound attenuation (cBUA) was assessed using QUS-2 (Quidel, Santa Clara, CA), speed of sound of tibial shaft (tSOS) using …

musculoskeletal diseasesAdultmedicine.medical_specialtyBone densityAdolescentEndocrinology Diabetes and MetabolismBone remodelingFractures BoneAbsorptiometry PhotonBone DensityMedicineHumansRadiology Nuclear Medicine and imagingOrthopedics and Sports MedicineProspective StudiesQuantitative computed tomographyProspective cohort studyChildFemoral neckUltrasonographyBone growthBone mineralmedicine.diagnostic_testbusiness.industryReproducibility of ResultsConcordance correlation coefficientmedicine.anatomical_structureFemaleRadiologybusinessNuclear medicineTomography X-Ray ComputedJournal of clinical densitometry : the official journal of the International Society for Clinical Densitometry
researchProduct

Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.

2005

Abstract During embryogenesis the bone tissue of craniomandibular joint (CMJ) is formed through two pathways: intramembranous ossification and endochondral ossification. The development process is under the control of regulatory factors.The osteoprotegerin (OPG) and the receptor activator of nuclear factor (NF)-κB ligand are key regulators of osteoclastogenesis. The aim of this study is the localization of OPG and RANKL mRNA and protein in the foetal CMJ by immunohistochemistry (IHC) and in situ hybridization (ISH). The main results were: OPG and RANKL mRNA and protein were co-localized in the same cell types; OPG and RANKL were specially immunolocated in osteogenic cells; immunolabeling wa…

musculoskeletal diseasesCartilage Articularmedicine.medical_specialtyReceptors Cytoplasmic and NuclearIn situ hybridizationBiologyBone tissueReceptors Tumor Necrosis FactorBone remodelingOsteoprotegerinOsteogenesisInternal medicineBone cellmedicineHumansRNA MessengerEndochondral ossificationIn Situ HybridizationGlycoproteinsMembrane GlycoproteinsReceptor Activator of Nuclear Factor-kappa BTemporomandibular JointRANK LigandOsteoprotegerinCell BiologyGeneral MedicineImmunohistochemistryCell biologyEndocrinologymedicine.anatomical_structureRANKLIntramembranous ossificationbiology.proteinCarrier ProteinsDevelopmental BiologyTissuecell
researchProduct

Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain

2012

Abstract Objective During orthodontic therapy the correct strength of mechanical strain plays a key role for bone remodelling during tooth movement. Aim of this study was to investigate the osteogenic differentiation of human periodontal ligament fibroblasts (HPdLF) depending on the applied strength of mechanical strain compared to osteoblasts (HOB). Design HPdLF and HOB were loaded with different strengths (1%, 5% and 10%) of static mechanical strain (SMS) for 12 h in vitro. Viability was verified by MTT and apoptosis by TUNEL assay. Gene expression of cyclin D1, collagen type-1 (COL-I), alkaline phosphatase (ALP), osteocalcin, osteoprotegerin (OPG) and receptor activator of the NF-κB liga…

musculoskeletal diseasesCell SurvivalPeriodontal LigamentGene ExpressionDentistryApoptosisEnzyme-Linked Immunosorbent AssayReal-Time Polymerase Chain ReactionCollagen Type IBone remodelingAndrologyCyclin D1OsteoprotegerinOsteogenesisIn Situ Nick-End LabelingHumansPeriodontal fiberCyclin D1RNA MessengerGeneral DentistryCells CulturedAnalysis of VarianceOsteoblastsTUNEL assaybiologybusiness.industryChemistryRANK LigandOsteoprotegerinCell DifferentiationCell BiologyGeneral MedicineFibroblastsAlkaline PhosphataseOtorhinolaryngologyRANKLOsteocalcinbiology.proteinAlkaline phosphataseStress MechanicalbusinessArchives of Oral Biology
researchProduct

COL1A1 Sp1 polymorphism associates with bone density in early puberty.

2006

Optimal acquisition of bone mass in puberty is a key determinant of the lifetime risk of osteoporosis and has a strong genetic basis. We investigated the relationship between the COL1A1 Sp1 polymorphism and BMD in early puberty, and how the genotypes relate to bone size and geometry as well as bone turnover and material properties in 247 10- to 13-year-old girls. Bone properties were measured using DXA, pQCT, and ultrasound. Also, serum P1NP, OC, B-ALP, and TRACP 5b were assessed. Our results showed that girls with the TT genotype had significantly lower BMC and BMD of the total body, lumbar spine, and proximal femur, as well as BUA at the calcaneus, than those with the GT and GG genotype. …

musculoskeletal diseasesPeak bone massmedicine.medical_specialtyHistologyTime FactorsBone densityAdolescentGenotypePhysiologyEndocrinology Diabetes and MetabolismOsteoporosisPuberty PrecociousCollagen Type IBone remodelingBone DensityInternal medicineGenotypeMedicineHumansChildPolymorphism GeneticProximal femurbusiness.industrymusculoskeletal systemmedicine.diseaseCollagen Type I alpha 1 ChainEndocrinologyFemaleCalcaneusbusinessBiomarkersEarly pubertyBone
researchProduct

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue

2016

Objectives Human leukocyte antigen (HLA)-B27 (B27) is the strongest genetic factor associated with development of Ankylosing Spondylitis and other spondyloarthropathies (SpA), yet the role it plays in disease pathogenesis remains unclear. We investigated the expression of potentially pathogenic non-conventional heavy chain forms (NC) of B27 in synovial and intestinal tissues obtained from SpA patients. We also determined the presence of NC-B27 in joints, lymphoid and gastrointestinal tissue from B27 transgenic (TG1) rats with M.tuberculosis-induced SpA. Methods Expression of NC-B27 in human SpA joints and gut and in (21-3 × 283-2)F1 HLA-B27/Huβ2m rat tissue was determined by immunohistochem…

musculoskeletal diseasesalpha-DefensinsHLA-B27 transgenic rat modelGastrointestinal DiseasesCD8 AntigensImmunologyGene ExpressionArticleSpondyloarthropathieAnimalsHumansHLA class I free-heavy chainImmunology and AllergySpondylitis AnkylosingSpondyloarthropathiesskin and connective tissue diseasesHLA-B27 AntigenHLA-B27CD11 AntigensHistocompatibility Antigens Class ISynovial MembraneReceptors KIR3DL2Arthritis ExperimentalR1HLA class I free-heavy chainsRatsDisease Models AnimalSettore MED/16 - ReumatologiaHLA class I free-heavy chains; HLA-B27; HLA-B27 transgenic rat model; Spondyloarthropathies; Immunology and Allergy; ImmunologyBone RemodelingRats Transgenic
researchProduct

Does hysterectomy with ovarian conservation affect bone metabolism and density?

2002

We evaluated whether hysterectomy with ovarian conservation (HYX) has an effect on bone metabolism and density in 176 healthy Caucasian postmenopausal women aged 48-59 years. Bone properties of the hip, spine, radius, tibia, and calcaneus were measured using different bone assessment modalities. In addition, bone turnover was assessed using serum bone-specific alkaline phosphatase (BAP), osteocalcin (OC), and tartrate-resistant acid phosphatase (TRAP) 5b as biomarkers. Our results showed that women having HYX had a significantly lower level of OC ( P = 0.017) and a marginally lower level of TRAP 5b ( P = 0.051) and higher bone mineral density (BMD) of the femoral neck ( P = 0.037) and lumba…

musculoskeletal diseasesmedicine.medical_specialtyBone densityEndocrinology Diabetes and MetabolismHysterectomyBone and BonesBone remodelingEndocrinologyBone DensityInternal medicineMedicineHumansOrthopedics and Sports MedicineTibiaFemoral neckBone mineralbiologybusiness.industryOvaryGeneral MedicineMiddle Agedmusculoskeletal systemPostmenopausemedicine.anatomical_structureEndocrinologyOsteocalcinbiology.proteinAlkaline phosphataseFemaleCalcaneusFollicle Stimulating HormonebusinessJournal of bone and mineral metabolism
researchProduct

Positive association of high-density lipoprotein cholesterol with lumbar and femoral neck bone mineral density in postmenopausal women.

2021

Abstract Objective Experimental studies suggest that lipids affect bone metabolism. We aimed to elucidate whether lipid levels are associated with bone mineral density (BMD) in a cohort of postmenopausal women. Design A cross-sectional study of participants in the Chronic Ailment Reduction after MENopause (CARMEN) cohort. Women underwent assessment of clinical and analytical parameters, including fasting lipid levels. BMD was assessed at both lumbar spine and hip. Homogeneity in the cohort was optimized by filtering out a series of confounding variables with a known impact on bone. Main outcome measures Association of BMD at lumbar spine and femoral neck with lipid levels. Results A total o…

musculoskeletal diseasesmedicine.medical_specialtyOsteoporosisUrologyGeneral Biochemistry Genetics and Molecular BiologyBone remodelingCohort Studies03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBone DensitymedicineHumans030212 general & internal medicineFemoral neckAgedBone mineral030219 obstetrics & reproductive medicineLumbar VertebraeCholesterolbusiness.industryFemur NeckCholesterol HDLObstetrics and GynecologyMiddle Agedmusculoskeletal systemmedicine.diseaseMenopausePostmenopausemedicine.anatomical_structurechemistryCohortlipids (amino acids peptides and proteins)FemalebusinessBody mass indexMaturitas
researchProduct

Management of Osteoporosis in Postmenopausal Women

2019

Osteoporosis is a noncommunicable disease with increasing incidence at a global level. The burden of the disease particularly concerns women. A drastic and rapid decline in the circulating levels of estrogens, a key regulator of bone metabolism, is responsible for the increase in bone loss after menopause. Cells with a role in bone metabolism, osteoblasts, osteoclasts and osteocytes, have estrogen receptors. The fall in estrogens increases the differentiation of osteoclasts from progenitors in the bone marrow. A significant expansion in the resorption process follows.

musculoskeletal diseasesmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentOsteoporosisEstrogen receptorDiseasemedicine.diseaseBone remodelingResorptionMenopauseEndocrinologymedicine.anatomical_structureInternal medicinemedicineBone marrowHormone therapybusiness
researchProduct